Cano Health, Inc. financial data

Symbol
CANO, CANO-WT on NYSE
Industry
Services-Offices & Clinics of Doctors of Medicine
Location
9725 Nw 117 Th Avenue, Suite 200, Miami, Florida
State of incorporation
Delaware
Fiscal year end
December 31
Former names
Jaws Acquisition Corp. (to 6/4/2021)
Latest financial report
Q1 2024 - May 10, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 31.4 % -81.1%
Debt-to-equity -543 % -231%
Return On Equity 251 %
Return On Assets -78.9 % -586%
Operating Margin -4.96 %

Shares

Label TTM Value / Value Unit Change %
Entity Public Float 339 M USD -70.6%
Weighted Average Number of Shares Outstanding, Basic 4.6 M shares +91.6%
Weighted Average Number of Shares Outstanding, Diluted 5.25 M shares +4.26%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.38 B USD +101%
Revenue from Contract with Customer, Excluding Assessed Tax 2.96 B USD +1.85%
Operating Income (Loss) -1.08 B USD -131%
Nonoperating Income (Expense) -100 M USD -338%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -1.52 B USD -211%
Income Tax Expense (Benefit) -1.78 M USD -265%
Net Income (Loss) Attributable to Parent -982 M USD -316%
Earnings Per Share, Basic -295 USD/shares -177%
Earnings Per Share, Diluted -322 USD/shares -202%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 54.2 M USD -77.6%
Other Assets, Current 13.8 M USD -48.1%
Assets, Current 255 M USD -18.7%
Property, Plant and Equipment, Net 126 M USD +95.6%
Operating Lease, Right-of-Use Asset 60 M USD -66.5%
Goodwill 0 USD -100%
Other Assets, Noncurrent 4.18 M USD -93.7%
Assets 1.05 B USD -46.2%
Liabilities, Current 267 M USD +24.8%
Operating Lease, Liability, Noncurrent 61.7 M USD -63.2%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 2.05 B USD +42.7%
Retained Earnings (Accumulated Deficit) -1.3 B USD -313%
Stockholders' Equity Attributable to Parent -882 M USD -414%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -1.01 B USD -300%
Liabilities and Equity 1.05 B USD -46.2%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -48.8 M USD -65.7%
Net Cash Provided by (Used in) Financing Activities 147 M USD +161%
Net Cash Provided by (Used in) Investing Activities 3.87 M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 102 M USD +482%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 178 M USD +297%
Interest Paid, Excluding Capitalized Interest, Operating Activities 805 K USD -96.8%
Deferred Tax Assets, Valuation Allowance 611 M USD +43.4%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 611 M USD +43.4%
Operating Lease, Liability 77.7 M USD -59.6%
Depreciation 45.2 M USD +166%
Payments to Acquire Property, Plant, and Equipment 814 K USD -84%
Lessee, Operating Lease, Liability, to be Paid 113 M USD -55.6%
Operating Lease, Liability, Current 13.7 M USD -44.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 17.7 M USD -46.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 19.9 M USD -44.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +15%
Deferred Income Tax Expense (Benefit) 0 USD -100%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 35.2 M USD -43%
Lessee, Operating Lease, Liability, to be Paid, Year Three 15.4 M USD -49%
Deferred Tax Assets, Operating Loss Carryforwards 92.9 M USD +196%
Deferred Federal Income Tax Expense (Benefit) 0 USD
Current Income Tax Expense (Benefit) -1.82 M USD -184%
Preferred Stock, Shares Authorized 10 M shares
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 13 M USD -53.1%
Operating Lease, Payments 36.7 M USD +34.9%
Additional Paid in Capital 414 M USD -30.4%
Current State and Local Tax Expense (Benefit) 145 K USD
Current Federal Tax Expense (Benefit) 0 USD -100%
Amortization of Intangible Assets 75.5 M USD -2.71%
Depreciation, Depletion and Amortization 18.4 M USD -32.5%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 18.3 M USD -139%
Deferred State and Local Income Tax Expense (Benefit) 0 USD
Interest Expense 106 M USD +46%